Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Medpace (MEDP)

Medpace extends PNC revolving credit note maturity to March 31, 2026

Neutral Impact 2 of 5 financing Written later

Medpace Holdings and subsidiaries signed Amendment No. 7 to its unsecured credit facility with PNC Bank, National Association, on March 28, 2025. The amendment extends the expiration date of the revolving credit note to March 31, 2026, keeping the company's existing borrowing arrangement in place for another year.

Key points

  • Agreement dated March 28, 2025 with PNC Bank, National Association, under the unsecured credit facility
  • Amendment No. 7 extends the revolving credit note expiration date to March 31, 2026
  • Medpace, Inc. is borrower and Medpace IntermediateCo, Inc. is guarantor; full text filed as Exhibit 10.1

The filing

CompanyMedpace (MEDP)
Form8-K, current report
Filed with the SECMar 31, 2025, 4:14 PM ET
Accession number0001668397-25-000037

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 31, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.